Stockreport

KalVista Pharmaceuticals Inc (KALV) Q3 2026 Earnings Call Highlights: Strong EKTERLY Launch and ... [Yahoo! Finance]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF Operating Expenses: Total operating expenses were $59.7 million, with $12 million in R&D expenses and $46.5 million in SG&A expenses. Cash Position: Sufficient to fun [Read more]